|
|
||||||||
2-Microglobulin Stabilizes a Highly Receptive State of MHC Class I Molecules1







* Laboratory of Immunology, MIGAL-Galilee Technology Center, Kiryat Shmona, Israel;
Department of Biology, Technion-Israel Institute of Technology, Haifa, Israel;
Department of Biotechnology, Tel-Hai Academic College, Upper Galilee, Israel; and
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
The magnitude of response elicited by CTL-inducing vaccines correlates with the density of MHC class I (MHC-I)-peptide complexes formed on the APC membrane. The MHC-I L chain,
2-microglobulin (
2m), governs complex stability. We reasoned that genetically converting
2m into an integral membrane protein should exert a marked stabilizing effect on the resulting MHC-I molecules and enhance vaccine efficacy. In the present study, we show that expression of membranal human
2m (h
2m) in mouse RMA-S cells elevates MHC-I thermal stability. RMA-S transfectants bind an exogenous peptide at concentrations 104- to 106-fold lower than parental RMA-S, as detected by complex-specific Abs and by T cell activation. Moreover, saturation of the transfectants MHC-I by exogenous peptide occurs within 1 min, as compared with
1 h required for parental cells. At saturation, however, level of peptide bound by modified cells is only 3- to 5-fold higher. Expression of native h
2m only results in marginal effect on the binding profile. Soluble
2m has no effect on the accelerated kinetics, but the kinetics of transfectants parallel that of parental cells in the presence of Abs to h
2m. Ab inhibition and coimmunoprecipitation analyses suggest that both prolonged persistence of peptide-receptive H chain/
2m heterodimers and fast heterodimer formation via lateral diffusion may contribute to stabilization. In vivo, peptide-loaded transfectants are considerably superior to parental cells in suppressing tumor growth. Our findings support the role of an allosteric mechanism in determining ternary MHC-I complex stability and propose membranal
2m as a novel scaffold for CTL induction.
This article has been cited by other articles:
![]() |
A. Margalit, H. M. Sheikhet, Y. Carmi, D. Berko, E. Tzehoval, L. Eisenbach, and G. Gross Induction of Antitumor Immunity by CTL Epitopes Genetically Linked to Membrane-Anchored {beta}2-Microglobulin J. Immunol., January 1, 2006; 176(1): 217 - 224. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |